Phase 3 trial results for an oral GLP-1 medication demonstrated significant improvement in type 2 diabetes management, building on injectable drug success.
Tag: Diabetes
Oral GLP-1 Drug for Type 2 Diabetes Shows Major Blood Sugar and Weight Loss in Trial
A new once-daily oral semaglutide variant delivered significant reductions in blood glucose and body weight in a major phase 3 clinical trial.
FDA Approves Inhaled Insulin Afrezza for Children with Diabetes
The US Food and Drug Administration grants approval for the use of inhaled insulin Afrezza in paediatric patients with type 1 and type 2 diabetes.
Reversing Prediabetes Cuts Risk of Deadly Heart Problems by 58%
A major study shows that returning blood sugar levels to normal from prediabetes dramatically reduces the danger of fatal cardiovascular events.
The New GLP-1 Pill Could Be a Diabetes Game-Changer — But Who Will Afford It?
Opinion on the promise and pricing challenges of a new oral GLP-1 medication that dramatically improves blood sugar in clinical trials.
Scientists Identify Genetic Variants That Reduce Effectiveness of GLP-1 Diabetes Drugs in 10 Percent of Population
Researchers discovered genetic variants carried by roughly one in ten people that significantly reduce the therapeutic response to popular GLP-1 medications.
New Diabetes Pill Burns Fat Without Hunger Suppression Unlike Ozempic
Experimental diabetes and obesity drug works by activating metabolism in skeletal muscle rather than suppressing appetite offering a new treatment pathway